Login to Your Account


Playing the blame game

"Get your act together or else ..." was the message Republican and Democrat alike delivered Wednesday to drug companies, insurers and pharmacy benefit managers (PBMs) during a House subcommittee hearing on the prescription drug supply chain and its impact on drug prices.

more »


Analysis

The Good Pharma Scorecard (GPS) released last week by the not-for-profit Bioethics International contained surprisingly good news. Two companies – Johnson & Johnson (J&J) and Sanofi SA – of 11 ranked on overall clinical trial transparency, based on drugs approved in 2014, achieved scores of 100 percent, tying them at the top of the list. Four others – Abbvie Inc., Celgene Corp., Merck & Co. Inc. and Astrazeneca plc – scored at or above the industry median of 91 percent.

read more »

Opinion


Partners in Focus